SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-13-031299
Filing Date
2013-08-09
Accepted
2013-08-09 07:17:08
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 BIOSPECIFICS TECHNOLOGIES CORP 10-Q 6-30-2013 form10q.htm 10-Q 470182
2 EXHIBIT 32 ex32.htm EX-32 5234
3 EXHIBIT 31 ex31.htm EX-31 11414
  Complete submission text file 0001140361-13-031299.txt   4357955

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bstc-20130630.xml EX-101.INS 321919
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20130630.xsd EX-101.SCH 22269
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20130630_cal.xml EX-101.CAL 36962
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20130630_def.xml EX-101.DEF 56875
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20130630_lab.xml EX-101.LAB 313754
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20130630_pre.xml EX-101.PRE 186225
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 131024421
SIC: 2834 Pharmaceutical Preparations